Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects
NCT02431312
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Interventions
BIOLOGICAL:
INO-1800
BIOLOGICAL:
INO-9112
DRUG:
Nucleos(t)ide Analogue Treatment
Sponsor
Inovio Pharmaceuticals